Preeclampsia drugs market to reach $2.37 billion by 2030 at 11.8% cagr, driven by rise in diabetes cases among pregnant women and growing maternal health risks.
Read MorePrecision oncology market to reach $175.38 billion by 2030 at 10.5% cagr, driven by increasing awareness and shift toward personalized therapies enabled by genomic technologies.
Read MorePrecision medicine market to reach $137.69 billion by 2030 at 9.4% cagr, driven by rising prevalence of cancer and growing demand for personalized treatment approaches.
Read MorePrebiotics for infant formula market to reach $2.47 billion by 2030 at 7.8% cagr, driven by rising adoption of organic products among health-conscious and eco-friendly families.
Read MorePost-traumatic stress disorder therapeutics market to reach $1.41 billion by 2030 at 3.4% cagr, driven by rising burden of ptsd cases across the globe.
Read MorePostpartum health supplements market to reach $2.26 billion by 2030 at 8.4% cagr, driven by rising birth rates supported by improved maternal healthcare and access to reproductive services.
Read MorePostmenopausal vaginal atrophy treatment market to reach $3.38 billion by 2030 at 8.2% cagr, driven by rising postmenopausal population resulting from longer life expectancy and global aging trends.
Read MorePost-marketing pharmacovigilance and medical information market to reach $11.89 billion by 2030 at 11.4% cagr, driven by rising incidence of adverse drug reactions due to polypharmacy.
Read MorePost-inflammatory hyperpigmentation treatment market to reach $2.56 billion by 2030 at 11.7% cagr, driven by increasing demand for non-invasive dermatology treatments with minimal recovery time.
Read MorePostherpetic neuralgia (phn) market to reach $1.06 billion by 2030 at 6.5% cagr, driven by increasing prevalence of chronic pain conditions linked to aging populations and degenerative diseases.
Read More
